ZURICH (dpa-AFX Broker) - Swiss bank Credit Suisse has given Sartorius a "neutral" rating and a price target of 450 euros. Analyst Dominic Lunn is positive about the company's long-term growth prospects in the bioprocess and laboratory products sectors. However, the share price rally since the beginning of the year already adequately reflects this, he wrote in a study published on Monday. Like the shares of its subsidiary Sartorius Stedim Biotech, they are trading at a premium to the industry average./gl/tih

Publication of the original study: 20.01.2023 / 14:59 / UTC First disclosure of the original study: 23.01.2023 / 05:00 / UTC

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------